ArticleClinical and translational medicine2025

Targeting c-Myc enhances immunotherapy efficacy in combination with Ras inhibitor in triple-negative breast cancer.

Xiaojie Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.